Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.6740
-0.0300 (-4.26%)
Nov 6, 2026, 3:22 PM CET
Stenocare Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12.54 | 7.02 | 2.23 | 3.76 | 4.49 | 1.89 | |
Revenue Growth | 121.03% | 214.56% | -40.61% | -16.30% | 137.54% | 852.38% |
Cost of Revenue | 9.19 | 5.8 | 7.66 | 9.94 | 10.9 | 7.9 |
Gross Profit | 3.35 | 1.22 | -5.42 | -6.19 | -6.41 | -6.01 |
Selling, General & Admin | 3.43 | 2.93 | 5.76 | 6.38 | 6.81 | 7.23 |
Operating Expenses | 4.66 | 3 | 9.48 | 9.76 | 10.12 | 8.07 |
Operating Income | -1.31 | -1.77 | -14.9 | -15.95 | -16.53 | -14.08 |
Interest Expense | -0.43 | -0.66 | -1.54 | -2.88 | -1.29 | -0.21 |
Interest & Investment Income | 0.01 | 0.01 | 0.03 | - | 0.02 | 0.03 |
Earnings From Equity Investments | 0.03 | 0.03 | -0 | - | -0.08 | - |
EBT Excluding Unusual Items | -1.74 | -2.39 | -16.41 | -18.82 | -17.89 | -14.26 |
Merger & Restructuring Charges | - | - | -13.05 | - | - | - |
Asset Writedown | - | - | -5.14 | - | - | - |
Pretax Income | -1.74 | -2.39 | -34.6 | -18.82 | -17.89 | -14.26 |
Income Tax Expense | - | - | -0.11 | -1.25 | -1.58 | -1.53 |
Net Income | -1.74 | -2.39 | -34.49 | -17.57 | -16.3 | -12.73 |
Net Income to Common | -1.74 | -2.39 | -34.49 | -17.57 | -16.3 | -12.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 40 | 19 | 14 | 11 | 12 |
Shares Outstanding (Diluted) | - | 40 | 19 | 14 | 11 | 12 |
Shares Change | - | 106.79% | 38.17% | 22.09% | -2.22% | 11.00% |
EPS (Basic) | - | -0.06 | -1.79 | -1.26 | -1.43 | -1.09 |
EPS (Diluted) | - | -0.06 | -1.79 | -1.26 | -1.43 | -1.09 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.11 | -7.2 | -7.19 | -10.22 | -15.97 | -16.61 |
Free Cash Flow Per Share | - | -0.18 | -0.37 | -0.73 | -1.40 | -1.42 |
Gross Margin | 26.70% | 17.42% | -243.02% | -164.58% | -142.77% | - |
Operating Margin | -10.48% | -25.26% | -667.78% | -424.32% | -368.13% | -744.89% |
Profit Margin | -13.87% | -34.05% | -1545.18% | -467.54% | -363.13% | -673.67% |
Free Cash Flow Margin | -16.81% | -102.61% | -321.93% | -271.87% | -355.68% | -879.03% |
EBITDA | -0.12 | -1.7 | -11.18 | -12.56 | -13.22 | -12.99 |
EBITDA Margin | -0.99% | -24.27% | - | - | -294.35% | - |
D&A For EBITDA | 1.19 | 0.07 | 3.72 | 3.38 | 3.31 | 1.09 |
EBIT | -1.31 | -1.77 | -14.9 | -15.95 | -16.53 | -14.08 |
EBIT Margin | -10.48% | -25.26% | - | - | - | - |